150 related articles for article (PubMed ID: 29312569)
21. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
22. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
Huang Y; Fu JF; Shi HB; Liu LR
Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
[TBL] [Abstract][Full Text] [Related]
23. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide.
Imai Y; Varela GM; Jackson MB; Graham MJ; Crooke RM; Ahima RS
Gastroenterology; 2007 May; 132(5):1947-54. PubMed ID: 17484887
[TBL] [Abstract][Full Text] [Related]
24. Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway.
Zhu W; Ding C; Huang P; Ran J; Lian P; Tang Y; Dai W; Huang X
Sci Rep; 2022 Apr; 12(1):5639. PubMed ID: 35379885
[TBL] [Abstract][Full Text] [Related]
25. LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA-378 Transcription and Inhibition of Ppargc1β Expression.
Zhang T; Duan J; Zhang L; Li Z; Steer CJ; Yan G; Song G
Hepatology; 2019 Apr; 69(4):1488-1503. PubMed ID: 30281809
[TBL] [Abstract][Full Text] [Related]
26. Extracts of Vine Tea Improve Diet-Induced Non-Alcoholic Steatohepatitis Through AMPK-LXRα Signaling.
Chen YJ; Song HY; Zhang ZW; Chen Q; Tang ZP; Gu M
Front Pharmacol; 2021; 12():711763. PubMed ID: 34393793
[TBL] [Abstract][Full Text] [Related]
27. Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A.
Jung TW; Youn BS; Choi HY; Lee SY; Hong HC; Yang SJ; Yoo HJ; Kim BH; Baik SH; Choi KM
Biochem Pharmacol; 2013 Oct; 86(7):960-9. PubMed ID: 23948064
[TBL] [Abstract][Full Text] [Related]
28. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?
Yang S; Lin HZ; Hwang J; Chacko VP; Diehl AM
Cancer Res; 2001 Jul; 61(13):5016-23. PubMed ID: 11431335
[TBL] [Abstract][Full Text] [Related]
29. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression.
Hwang HJ; Jung TW; Kim BH; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
Biochem Pharmacol; 2015 Nov; 98(1):157-66. PubMed ID: 26297911
[TBL] [Abstract][Full Text] [Related]
30. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
[TBL] [Abstract][Full Text] [Related]
31. Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.
Stacchiotti A; Favero G; Lavazza A; Golic I; Aleksic M; Korac A; Rodella LF; Rezzani R
PLoS One; 2016; 11(1):e0148115. PubMed ID: 26824477
[TBL] [Abstract][Full Text] [Related]
32. Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK.
Lee YH; Yun MR; Kim HM; Jeon BH; Park BC; Lee BW; Kang ES; Lee HC; Park YW; Cha BS
Int J Obes (Lond); 2016 Feb; 40(2):356-65. PubMed ID: 26315841
[TBL] [Abstract][Full Text] [Related]
33. Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition.
Karavia EA; Hatziri A; Kalogeropoulou C; Papachristou NI; Xepapadaki E; Constantinou C; Natsos A; Petropoulou PI; Sasson S; Papachristou DJ; Kypreos KE
Eur J Pharmacol; 2015 Nov; 766():76-85. PubMed ID: 26420354
[TBL] [Abstract][Full Text] [Related]
34. Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.
Kim MS; Lee KT; Iseli TJ; Hoy AJ; George J; Grewal T; Roufogalis BD
Liver Int; 2013 Nov; 33(10):1583-93. PubMed ID: 23998390
[TBL] [Abstract][Full Text] [Related]
35. Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.
Nowak M; Helleboid-Chapman A; Jakel H; Martin G; Duran-Sandoval D; Staels B; Rubin EM; Pennacchio LA; Taskinen MR; Fruchart-Najib J; Fruchart JC
Mol Cell Biol; 2005 Feb; 25(4):1537-48. PubMed ID: 15684402
[TBL] [Abstract][Full Text] [Related]
36. AMPK induces MUC5B expression via p38 MAPK in NCI-H292 airway epithelial cells.
Bae CH; Kim JW; Ye SB; Song SY; Kim YW; Park SY; Kim YD
Biochem Biophys Res Commun; 2011 Jun; 409(4):669-74. PubMed ID: 21619869
[TBL] [Abstract][Full Text] [Related]
37. Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway.
Cho K; Chung JY; Cho SK; Shin HW; Jang IJ; Park JW; Yu KS; Cho JY
Sci Rep; 2015 Jan; 5():8145. PubMed ID: 25634597
[TBL] [Abstract][Full Text] [Related]
38. Defective leptin-AMP-dependent kinase pathway induces nitric oxide release and contributes to mitochondrial dysfunction and obesity in ob/ob mice.
Finocchietto PV; Holod S; Barreyro F; Peralta JG; Alippe Y; Giovambattista A; Carreras MC; Poderoso JJ
Antioxid Redox Signal; 2011 Nov; 15(9):2395-406. PubMed ID: 21529143
[TBL] [Abstract][Full Text] [Related]
39. MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.
Ohyama T; Sato K; Yamazaki Y; Hashizume H; Horiguchi N; Kakizaki S; Mori M; Kusano M; Yamada M
World J Gastroenterol; 2014 Nov; 20(43):16227-35. PubMed ID: 25473177
[TBL] [Abstract][Full Text] [Related]
40. GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.
Collin de l'Hortet A; Zerrad-Saadi A; Prip-Buus C; Fauveau V; Helmy N; Ziol M; Vons C; Billot K; Baud V; Gilgenkrantz H; Guidotti JE
Endocrinology; 2014 Jul; 155(7):2545-54. PubMed ID: 24708244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
